Functional defects in NOD2 signaling in experimental and human Crohn disease

References

• Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 2012; 148:1258 - 70; http://dx.doi.org/10.1016/j.cell.2012.01.035; PMID: 22424233
   PubMed Web of Science ®Google Scholar
• Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008; 453:620 - 5; http://dx.doi.org/10.1038/nature07008; PMID: 18509436
   PubMed Web of Science ®Google Scholar
• Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science 2009; 326:1694 - 7; http://dx.doi.org/10.1126/science.1177486; PMID: 19892944
   PubMed Web of Science ®Google Scholar
• Harrison OJ, Maloy KJ. Innate immune activation in intestinal homeostasis. J Innate Immun 2011; 3:585 - 93; http://dx.doi.org/10.1159/000330913; PMID: 21912101
   PubMed Web of Science ®Google Scholar
• Medzhitov R, Janeway CA Jr.. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997; 91:295 - 8; http://dx.doi.org/10.1016/S0092-8674(00)80412-2; PMID: 9363937
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4:499 - 511; http://dx.doi.org/10.1038/nri1391; PMID: 15229469
   PubMed Web of Science ®Google Scholar
• Palm NW, Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol Rev 2009; 227:221 - 33; http://dx.doi.org/10.1111/j.1600-065X.2008.00731.x; PMID: 19120487
   PubMed Web of Science ®Google Scholar
• Fukata M, Arditi M. The role of pattern recognition receptors in intestinal inflammation. Mucosal Immunol 2013; 6:451 - 63; http://dx.doi.org/10.1038/mi.2013.13; PMID: 23515136
   PubMed Web of Science ®Google Scholar
• Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011; 474:298 - 306; http://dx.doi.org/10.1038/nature10208; PMID: 21677746
   PubMed Web of Science ®Google Scholar
• Cominelli F. Cytokine-based therapies for Crohn’s disease--new paradigms. N Engl J Med 2004; 351:2045 - 8; http://dx.doi.org/10.1056/NEJMp048253; PMID: 15537904
   PubMed Web of Science ®Google Scholar
• Arseneau KO, Tamagawa H, Pizarro TT, Cominelli F. Innate and adaptive immune responses related to IBD pathogenesis. Curr Gastroenterol Rep 2007; 9:508 - 12; http://dx.doi.org/10.1007/s11894-007-0067-3; PMID: 18377804
   PubMedGoogle Scholar
• Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM, et al, NIDDK IBD Genetics Consortium, Belgian-French IBD Consortium, Wellcome Trust Case Control Consortium. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet 2008; 40:955 - 62; http://dx.doi.org/10.1038/ng.175; PMID: 18587394
   PubMed Web of Science ®Google Scholar
• Strober W, Watanabe T. NOD2, an intracellular innate immune sensor involved in host defense and Crohn’s disease. Mucosal Immunol 2011; 4:484 - 95; http://dx.doi.org/10.1038/mi.2011.29; PMID: 21750585
   PubMed Web of Science ®Google Scholar
• Inohara N, Nuñez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 2003; 3:371 - 82; http://dx.doi.org/10.1038/nri1086; PMID: 12766759
   PubMed Web of Science ®Google Scholar
• Gutierrez O, Pipaon C, Inohara N, Fontalba A, Ogura Y, Prosper F, Nunez G, Fernandez-Luna JL. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem 2002; 277:41701 - 5; http://dx.doi.org/10.1074/jbc.M206473200; PMID: 12194982
   PubMed Web of Science ®Google Scholar
• Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NFkappaB. J Biol Chem 2001; 276:4812 - 8; http://dx.doi.org/10.1074/jbc.M008072200; PMID: 11087742
   PubMed Web of Science ®Google Scholar
• Philpott DJ, Sorbara MT, Robertson SJ, Croitoru K, Girardin SE. NOD proteins: regulators of inflammation in health and disease. Nat Rev Immunol 2014; 14:9 - 23; http://dx.doi.org/10.1038/nri3565; PMID: 24336102
   PubMed Web of Science ®Google Scholar
• Kim JY, Omori E, Matsumoto K, Núñez G, Ninomiya-Tsuji J. TAK1 is a central mediator of NOD2 signaling in epidermal cells. J Biol Chem 2008; 283:137 - 44; http://dx.doi.org/10.1074/jbc.M704746200; PMID: 17965022
   PubMed Web of Science ®Google Scholar
• Park JH, Kim YG, McDonald C, Kanneganti TD, Hasegawa M, Body-Malapel M, Inohara N, Núñez G. RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J Immunol 2007; 178:2380 - 6; PMID: 17277144
   PubMed Web of Science ®Google Scholar
• Wagner CS, Cresswell P. TLR and nucleotide-binding oligomerization domain-like receptor signals differentially regulate exogenous antigen presentation. J Immunol 2012; 188:686 - 93; http://dx.doi.org/10.4049/jimmunol.1102214; PMID: 22156493
   PubMed Web of Science ®Google Scholar
• Cooney R, Baker J, Brain O, Danis B, Pichulik T, Allan P, Ferguson DJ, Campbell BJ, Jewell D, Simmons A. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 2010; 16:90 - 7; http://dx.doi.org/10.1038/nm.2069; PMID: 19966812
   PubMed Web of Science ®Google Scholar
• Homer CR, Richmond AL, Rebert NA, Achkar JP, McDonald C. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn’s disease pathogenesis. Gastroenterology 2010; 139:1630 - 41, e1-2; http://dx.doi.org/10.1053/j.gastro.2010.07.006; PMID: 20637199
   PubMed Web of Science ®Google Scholar
• Bonen DK, Ogura Y, Nicolae DL, Inohara N, Saab L, Tanabe T, Chen FF, Foster SJ, Duerr RH, Brant SR, et al. Crohn’s disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 2003; 124:140 - 6; http://dx.doi.org/10.1053/gast.2003.50019; PMID: 12512038
   PubMed Web of Science ®Google Scholar
• Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, Fukase K, Inamura S, Kusumoto S, Hashimoto M, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn’s disease. J Biol Chem 2003; 278:5509 - 12; http://dx.doi.org/10.1074/jbc.C200673200; PMID: 12514169
   PubMed Web of Science ®Google Scholar
• Strober W, Kitani A, Fuss I, Asano N, Watanabe T. The molecular basis of NOD2 susceptibility mutations in Crohn’s disease. Mucosal Immunol 2008; 1:Suppl 1 S5 - 9; http://dx.doi.org/10.1038/mi.2008.42; PMID: 19079230
   PubMed Web of Science ®Google Scholar
• Van Limbergen J, Wilson DC, Satsangi J. The genetics of Crohn’s disease. Annu Rev Genomics Hum Genet 2009; 10:89 - 116; http://dx.doi.org/10.1146/annurev-genom-082908-150013; PMID: 19453248
   PubMed Web of Science ®Google Scholar
• Corridoni D, Kodani T, Rodriguez-Palacios A, Pizarro TT, Xin W, Nickerson KP, McDonald C, Ley KF, Abbott DW, Cominelli F. Dysregulated NOD2 predisposes SAMP1/YitFc mice to chronic intestinal inflammation. Proc Natl Acad Sci U S A 2013; 110:16999 - 7004; http://dx.doi.org/10.1073/pnas.1311657110; PMID: 24082103
   PubMed Web of Science ®Google Scholar
• Pizarro TT, Pastorelli L, Bamias G, Garg RR, Reuter BK, Mercado JR, Chieppa M, Arseneau KO, Ley K, Cominelli F. SAMP1/YitFc mouse strain: a spontaneous model of Crohn’s disease-like ileitis. Inflamm Bowel Dis 2011; 17:2566 - 84; http://dx.doi.org/10.1002/ibd.21638; PMID: 21557393
   PubMed Web of Science ®Google Scholar
• Watanabe T, Asano N, Murray PJ, Ozato K, Tailor P, Fuss IJ, Kitani A, Strober W. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J Clin Invest 2008; 118:545 - 59; PMID: 18188453
   PubMed Web of Science ®Google Scholar
• Casanova JL, Abel L. Revisiting Crohn’s disease as a primary immunodeficiency of macrophages. J Exp Med 2009; 206:1839 - 43; http://dx.doi.org/10.1084/jem.20091683; PMID: 19687225
   PubMed Web of Science ®Google Scholar
• Marks DJ, Harbord MW, MacAllister R, Rahman FZ, Young J, Al-Lazikani B, Lees W, Novelli M, Bloom S, Segal AW. Defective acute inflammation in Crohn’s disease: a clinical investigation. Lancet 2006; 367:668 - 78; http://dx.doi.org/10.1016/S0140-6736(06)68265-2; PMID: 16503465
   PubMed Web of Science ®Google Scholar
• Smith AM, Rahman FZ, Hayee B, Graham SJ, Marks DJ, Sewell GW, Palmer CD, Wilde J, Foxwell BM, Gloger IS, et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn’s disease. J Exp Med 2009; 206:1883 - 97; http://dx.doi.org/10.1084/jem.20091233; PMID: 19652016
   PubMed Web of Science ®Google Scholar
• Netea MG, Ferwerda G, de Jong DJ, Jansen T, Jacobs L, Kramer M, Naber TH, Drenth JP, Girardin SE, Kullberg BJ, et al. Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J Immunol 2005; 174:6518 - 23; PMID: 15879155
   PubMed Web of Science ®Google Scholar
• Uehara A, Yang S, Fujimoto Y, Fukase K, Kusumoto S, Shibata K, Sugawara S, Takada H. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell Microbiol 2005; 7:53 - 61; http://dx.doi.org/10.1111/j.1462-5822.2004.00433.x; PMID: 15617523
   PubMed Web of Science ®Google Scholar
• Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17:1 - 14; http://dx.doi.org/10.1093/intimm/dxh186; PMID: 15585605
   PubMed Web of Science ®Google Scholar
• Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol 2004; 5:975 - 9; http://dx.doi.org/10.1038/ni1116; PMID: 15454920
   PubMed Web of Science ®Google Scholar
• Kim YG, Park JH, Shaw MH, Franchi L, Inohara N, Núñez G. The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. Immunity 2008; 28:246 - 57; http://dx.doi.org/10.1016/j.immuni.2007.12.012; PMID: 18261938
   PubMed Web of Science ®Google Scholar
• Jun JC, Cominelli F, Abbott DW. RIP2 activity in inflammatory disease and implications for novel therapeutics. J Leukoc Biol 2013; 94:927 - 32; http://dx.doi.org/10.1189/jlb.0213109; PMID: 23794710
   PubMed Web of Science ®Google Scholar
• Tigno-Aranjuez JT, Asara JM, Abbott DW. Inhibition of RIP2’s tyrosine kinase activity limits NOD2-driven cytokine responses. Genes Dev 2010; 24:2666 - 77; http://dx.doi.org/10.1101/gad.1964410; PMID: 21123652
   PubMed Web of Science ®Google Scholar
• Tigno-Aranjuez JT, Abbott DW. Ubiquitination and phosphorylation in the regulation of NOD2 signaling and NOD2-mediated disease. Biochim Biophys Acta 2012; 1823:2022 - 8; http://dx.doi.org/10.1016/j.bbamcr.2012.03.017; PMID: 22522061
   PubMed Web of Science ®Google Scholar
• Bamias G, Corridoni D, Pizarro TT, Cominelli F. New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation. Cytokine 2012; 59:451 - 9; http://dx.doi.org/10.1016/j.cyto.2012.06.014; PMID: 22795953
   PubMed Web of Science ®Google Scholar
• Corridoni D, Pastorelli L, Mattioli B, Locovei S, Ishikawa D, Arseneau KO, Chieppa M, Cominelli F, Pizarro TT. Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNFdependent mechanism. PLoS One 2012; 7:e42067; http://dx.doi.org/10.1371/journal.pone.0042067; PMID: 22848704
   PubMed Web of Science ®Google Scholar
• Pagnini C, Saeed R, Bamias G, Arseneau KO, Pizarro TT, Cominelli F. Probiotics promote gut health through stimulation of epithelial innate immunity. Proc Natl Acad Sci U S A 2010; 107:454 - 9; http://dx.doi.org/10.1073/pnas.0910307107; PMID: 20018654
   PubMed Web of Science ®Google Scholar
• Reuter BK, Pizarro TT. Commentary: the role of the IL-18 system and other members of the IL-1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe?. Eur J Immunol 2004; 34:2347 - 55; http://dx.doi.org/10.1002/eji.200425351; PMID: 15307167
   PubMed Web of Science ®Google Scholar
• Pastorelli L, De Salvo C, Vecchi M, Pizarro TT. The role of IL-33 in gut mucosal inflammation. Mediators Inflamm 2013; 2013:608187; http://dx.doi.org/10.1155/2013/608187; PMID: 23766561
   PubMed Web of Science ®Google Scholar
• Negroni A, Stronati L, Pierdomenico M, Tirindelli D, Di Nardo G, Mancini V, Maiella G, Cucchiara S. Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn’s disease. Inflamm Bowel Dis 2009; 15:1145 - 54; http://dx.doi.org/10.1002/ibd.20907; PMID: 19266573
   PubMed Web of Science ®Google Scholar
• Jamontt J, Petit S, Clark N, Parkinson SJ, Smith P. Nucleotide-binding oligomerization domain 2 signaling promotes hyperresponsive macrophages and colitis in IL-10-deficient mice. J Immunol 2013; 190:2948 - 58; http://dx.doi.org/10.4049/jimmunol.1201332; PMID: 23396949
   PubMed Web of Science ®Google Scholar